327 related articles for article (PubMed ID: 9809372)
1. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS; Bonetti B; Cannella B
Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
Warzocha K; Bienvenu J; Coiffier B; Salles G
Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
[TBL] [Abstract][Full Text] [Related]
4. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines.
Phillips TA; Ni J; Hunt JS
Placenta; 2001; 22(8-9):663-72. PubMed ID: 11597186
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis.
Bonetti B; Raine CS
Ann Neurol; 1997 Jul; 42(1):74-84. PubMed ID: 9225688
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
Hochman PS; Majeau GR; Mackay F; Browning JL
J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
[TBL] [Abstract][Full Text] [Related]
8. A family of ligands for the TNF receptor superfamily.
Cosman D
Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
[TBL] [Abstract][Full Text] [Related]
9. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
[TBL] [Abstract][Full Text] [Related]
10. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA
J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113
[TBL] [Abstract][Full Text] [Related]
11. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
13. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN
Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
[TBL] [Abstract][Full Text] [Related]
14. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
Sacca R; Cuff CA; Lesslauer W; Ruddle NH
J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
[TBL] [Abstract][Full Text] [Related]
15. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
[TBL] [Abstract][Full Text] [Related]
16. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression.
Force WR; Walter BN; Hession C; Tizard R; Kozak CA; Browning JL; Ware CF
J Immunol; 1995 Dec; 155(11):5280-8. PubMed ID: 7594541
[TBL] [Abstract][Full Text] [Related]
17. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
[TBL] [Abstract][Full Text] [Related]
18. Lymphotoxin and LIGHT signaling pathways and target genes.
Schneider K; Potter KG; Ware CF
Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
[TBL] [Abstract][Full Text] [Related]
19. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
Matsumoto M
J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
[TBL] [Abstract][Full Text] [Related]
20. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
